Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Airflow Obstruction and C… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Airflow Obstruction and Cardio-metabolic Comorbidities

Artikel i vetenskaplig tidskrift
Författare F. J. J. Triest
M. Studnicka
F. M. E. Franssen
W. M. Vollmer
B. Lamprecht
E. F. M. Wouters
P. G. J. Burney
Lowie E G W Vanfleteren
Publicerad i Copd-Journal of Chronic Obstructive Pulmonary Disease
Volym 16
Nummer/häfte 2
Sidor 109-117
ISSN 1541-2555
Publiceringsår 2019
Publicerad vid Institutionen för medicin
Sidor 109-117
Språk en
Länkar dx.doi.org/10.1080/15412555.2019.16...
Ämnesord Airflow obstruction, COPD, comorbidity, cardiovascular, hypertension, diabetes, coronary-heart-disease, cardiovascular risk-factors, blood-pressure, copd, prevalence, morbidity, smoking, Respiratory System
Ämneskategorier Kardiovaskulär medicin

Sammanfattning

Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and often co-exists with cardiovascular disease (CVD), hypertension and diabetes. This international study assessed the association between airflow obstruction and these comorbidities. 23,623 participants (47.5% males, 19.0% current smokers, age: 55.1 +/- 10.8 years) in 33 centers in the Burden of Obstructive Lung Disease (BOLD) initiative were included. 10.4% of subjects had airflow obstruction. Self-reports of physician-diagnosed CVD (heart disease or stroke), hypertension and diabetes were regressed against airflow obstruction (post-bronchodilator FEV1/FVC < 5th percentile of reference values), adjusting for age, sex, smoking (including pack-years), body mass index and education. Analyses were undertaken within center and meta-analyzed across centers checking heterogeneity using the I-2-statistic. Crude odds ratios for the association with airflow obstruction were 1.42 (95% CI: 1.20-1.69) for CVD, 1.24 (1.02-1.51) for hypertension, and 0.93 (0.76-1.15) for diabetes. After adjustment these were 1.00 (0.86-1.16) (I-2:6%) for CVD, 1.14 (0.99-1.31) (I-2:53%) for hypertension, and 0.76 (0.64-0.89) (I-2:1%) for diabetes with similar results for men and women, smokers and nonsmokers, in richer and poorer centers. Alternatively defining airflow obstruction by FEV1/FVC < 2.5th percentile or 0.70, did not yield significant other results. In conclusion, the associations of CVD and hypertension with airflow obstruction in the general population are largely explained by age and smoking habits. The adjusted risk for diabetes is lower in subjects with airflow obstruction. These findings emphasize the role of common risk factors in explaining the coexistence of cardio-metabolic comorbidities and COPD.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?